Catalyst Wire Dossier Catalyst Wire Dossier

intranasal sufentanil

sufentanil
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intranasal sufentanil, covering 2023-12-26 to 2023-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric [Phase 3]

See pricing